KDM4D and colorectal carcinoma: Chen et al. found that KDM4D coactivated SP-1 to promote interferon gamma receptor 1 expression, which enhanced STAT3-Interferon regulatory factor 1 signaling and promoted PD-L1 expression through H3K9 demethylation for immune evasion in CRC [31].